Beneficient Secures $3M in Preferred Stock Financing at Premium to Current Price

summarizeSummary

Beneficient announced the closing of a $3 million primary capital transaction, issuing Series B-9 Resettable Convertible Preferred Stock with an initial conversion price above the current market price.

check_boxKey Events

• $3 Million Capital Raise

  Beneficient closed a primary capital transaction, acquiring a limited partner interest in an investment fund with a net asset value of $3,022,728.

• Issuance of Convertible Preferred Stock

  The company issued 302,273 shares of Series B-9 Resettable Convertible Preferred Stock to a customer.

• Conversion Terms

  The preferred stock is convertible into Class A Common Stock at an initial price of $7.1332 per share, which is above the current market price. The conversion price is subject to monthly resets with a floor of $5.3499 per share, and a maximum of 565,007 Class A Common Stock shares may be issued.

• Capital Structure Impact

  The Series B-9 Preferred Stock ranks pari passu with Class A Common Stock for dividends and liquidation but is junior to existing preferred stock series and all indebtedness.

auto_awesomeAnalysis

This capital raise is significant for Beneficient, representing over 4% of its current market capitalization. While the issuance of convertible preferred stock introduces potential dilution, the initial conversion price of $7.1332 per share is notably above the current stock price of $5.15, suggesting a degree of institutional confidence in the company's future value. The preferred stock includes a reset feature for its conversion price, with a floor of $5.3499, which could lead to increased dilution if the stock price declines. This financing provides crucial capital for the company's operations and growth initiatives.